Day: July 20, 2020

Alliance Global signs exclusive distribution agreement with BioLegend

July, 2020 – BioLegend, Inc., a leading manufacturer and supplier of antibodies and reagents that covers a diverse set of research areas including immunology, cancer research, neuroscience, proteogenomics, stem cells, and other emerging sectors, has signed an exclusive distribution agreement with Alliance Global (AGBL) Group. “BioLegend is continually expanding its

Read More »